Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02826486 |
|---|---|
| Brief Title: | Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) (COMBAT) |
| First Submitted : | June 21, 2016 |
| First Submitted that Met QC Criteria : | July 5, 2016 |
| First Posted : | July 11, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 1, 2020 |
| Last Update Posted : | January 3, 2020 |